BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9642682)

  • 21. Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.
    Zink WE; Anderson E; Boyle J; Hock L; Rodriguez-Sierra J; Xiong H; Gendelman HE; Persidsky Y
    J Neurosci; 2002 Mar; 22(6):2096-105. PubMed ID: 11896149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders.
    Mattson MP; Duan W; Chan SL; Camandola S
    J Mol Neurosci; 1999; 13(1-2):17-30. PubMed ID: 10691289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation.
    Kato S; Nakashima K; Horiuchi S; Nagai R; Cleveland DW; Liu J; Hirano A; Takikawa M; Kato M; Nakano I; Sakoda S; Asayama K; Ohama E
    Neuropathology; 2001 Mar; 21(1):67-81. PubMed ID: 11304045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.
    Kato S; Saito M; Hirano A; Ohama E
    Histol Histopathol; 1999 Jul; 14(3):973-89. PubMed ID: 10425565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.
    Chou SM; Wang HS; Taniguchi A; Bucala R
    Mol Med; 1998 May; 4(5):324-32. PubMed ID: 9642682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Hirano A; Kato S; Nagai R; Horiuchi S; Komori T; Umahara T; Asayama K; Kobayashi M
    Acta Neuropathol; 1999 Mar; 97(3):240-6. PubMed ID: 10090670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study.
    Chou SM; Han CY; Wang HS; Vlassara H; Bucala R
    J Neurol Sci; 1999 Oct; 169(1-2):87-92. PubMed ID: 10540014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation.
    Kato S; Horiuchi S; Liu J; Cleveland DW; Shibata N; Nakashima K; Nagai R; Hirano A; Takikawa M; Kato M; Nakano I; Ohama E
    Acta Neuropathol; 2000 Nov; 100(5):490-505. PubMed ID: 11045671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS.
    Ince PG; Tomkins J; Slade JY; Thatcher NM; Shaw PJ
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):895-904. PubMed ID: 9786240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Nagai R; Miyata S; Jono T; Horiuchi S; Hirano A; Kato S; Sasaki S; Asayama K; Kobayashi M
    Acta Neuropathol; 2000 Sep; 100(3):275-84. PubMed ID: 10965797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis.
    Beal MF; Ferrante RJ; Browne SE; Matthews RT; Kowall NW; Brown RH
    Ann Neurol; 1997 Oct; 42(4):644-54. PubMed ID: 9382477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathology of amyotrophic lateral sclerosis: new perspectives on an old disease.
    Chou SM
    J Formos Med Assoc; 1997 Jul; 96(7):488-98. PubMed ID: 9262052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant.
    Bruijn LI; Beal MF; Becher MW; Schulz JB; Wong PC; Price DL; Cleveland DW
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7606-11. PubMed ID: 9207139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis.
    Abe K; Pan LH; Watanabe M; Konno H; Kato T; Itoyama Y
    Neurol Res; 1997 Apr; 19(2):124-8. PubMed ID: 9175139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus.
    Ryle C; Leow CK; Donaghy M
    Muscle Nerve; 1997 May; 20(5):577-84. PubMed ID: 9140364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Widespread peroxynitrite-mediated damage in Alzheimer's disease.
    Smith MA; Richey Harris PL; Sayre LM; Beckman JS; Perry G
    J Neurosci; 1997 Apr; 17(8):2653-7. PubMed ID: 9092586
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.